BackAclaris Therapeutics Overview

Aclaris Therapeutics Other Liabilities

Track Aclaris Therapeutics's other liabilities ($11M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Other Liabilities
$11.30M

Peer average

Loading

Aclaris Therapeutics Other Liabilities History

Loading

Aclaris Therapeutics vs. peers: Other Liabilities Comparison

Loading

Aclaris Therapeutics Other Liabilities Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Aclaris Therapeutics (ACRS) FAQ

As of the most recent data (June 2026), ACRS shows a other liabilities of $11M. In the prior-year period, the figure was $0. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, ACRS's other liabilities is now $11M (was $0). Pairing that YoY change with peer averages gives a clearer picture of whether Aclaris Therapeutics is outperforming or lagging.

Tracking ACRS's other liabilities over time shows whether Aclaris Therapeutics is scaling, shrinking, or reshaping that part of the business. The current reading is $11M In the prior-year period, the figure was $0. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this other liabilities page, Stockcircle has Aclaris Therapeutics's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect other liabilities (currently $11M) with ownership activity and broader fundamentals.

Aclaris Therapeutics's other liabilities is $11M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.